Current concepts in osteolysis

Journal of Bone and Joint Surgery - Series B

Volumn 94 B, Issue 1, 2012, Pages 10-15

  Ollivere, B ^a   Wimhurst, J A ^a   Clark, I M ^a,b   Donell, S T ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROPLASTY; HUMAN; MACROPHAGE ACTIVATION; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIPROSTHETIC OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT, HIP; HUMANS; MACROPHAGE ACTIVATION; OSTEOCLASTS; OSTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 84855564237     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.94B1.28047     Document Type: Review

References (90)

1. Field RE, Cronin MD, Singh PJ. The Oxford hip scores for primary and revision hip replacement. J Bone Joint Surg [Br] 2005;87-B:618-622. (Pubitemid 40711631)
2. Ollivere B, Darrah C, Brankin RC, Donell ST, Walton NP. The continued value of clinical and radiological surveillance: the Charnley Elite Plus hip replacement system at 12 years. J Bone Joint Surg [Br] 2009;91-B:720-724.
3. Ollivere B, Duckett S, August A, Porteous M. The Birmingham Hip Resurfacing: 5-year clinical and radiographic results from a District General Hospital. Int Orthop 2009;34:631-634.
4. Wroblewski BM, Fleming PA, Siney PD. Charnley low-frictional torque arthroplasty of the hip: 20-to-30 year results. J Bone Joint Surg [Br] 1999;81-B:427-430. (Pubitemid 29245894)
5. Mulhall KJ, Saleh KJ, Thompson CA, Severson EP, Palmer DH. Results of bilateral combined hip and knee arthroplasty in very young patients with juvenile rheumatoid arthritis. Arch Orthop Trauma Surg 2008;128:249-254. (Pubitemid 351234304)
6. Onsten I, Bengnér U, Besjakov J. Socket migration after Charnley arthroplasty in rheumatoid arthritis and osteoarthritis: a roentgen stereophotogrammetric study. J Bone Joint Surg [Br] 1993;75-B:677-680. (Pubitemid 23267926)
7. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop 2007;78:206-210. (Pubitemid 46676661)
8. Bhan S, Eachempati KK, Malhotra R. Primary cementless total hip arthroplasty for bony ankylosis in patients with ankylosing spondylitis. J Arthroplasty 2008;23:859-866.
9. Vander Cruyssen B, Muñoz-Gomariz E, Font P. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) 2010;49:73-81.
10. Liu YE, Hu S, Chan SP, Sathappan SS. The epidemiology and surgical outcomes of patients undergoing primary total hip replacement: an Asian perspective. Singapore Med J 2009;50:15-19.
11. Restrepo C, Lettich T, Roberts N, Parvizi J, Hozack WJ. Uncemented total hip arthroplasty in patients less than twenty-years. Acta Orthop Belg 2008;74:615-622.
12. Simon JP, Robbens E, Maes M, Bellemans J. Single-stage bilateral total hip arthroplasty in patients less than 35 years: forty arthroplasties with 5-17 years followup. Acta Orthop Belg 2009;75:189-199.
13. Dudkiewicz I, Salai M, Chechik A, Ganel A. Total hip arthroplasty after childhood septic hip in patients younger than 25 years of age. J Pediatr Orthop 2000;20:585-587.
14. Kim YH, Oh SH, Kim JS. Total hip arthroplasty in adult patients who had childhood infection of the hip. J Bone Joint Surg [Am] 2003;85-A:198-204.
15. Park YS, Moon YW, Lim SJ, Oh I, Lim JS. Prognostic factors influencing the functional outcome of total hip arthroplasty for hip infection sequelae. J Arthroplasty 2005;20:608-613. (Pubitemid 41073474)
16. Habermann B, Eberhardt C, Hovy L, et al. Total hip replacement in patients with severe bleeding disorders: a 30 years single center experience. Int Orthop 2007;31:17-21. (Pubitemid 46208218)
17. Amstutz HC, Le Duff MJ, Harvey N, Hoberg M. Improved survivorship of hybrid metal-on-metal hip resurfacing with second-generation techniques for Crowe-I and II developmental dysplasia of the hip. J Bone Joint Surg [Am] 2008;90-A(Suppl):12-20.
18. Biant LC, Bruce WJ, Assini JB, Walker PM, Walsh WR. Primary total hip arthroplasty in severe developmental dysplasia of the hip: ten-year results using a cementless modular stem. J Arthroplasty 2009;24:27-32.
19. Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg [Am] 2007;89-A:526-533. (Pubitemid 46365352)
20. Baker RP, Squires B, Gargan MF, Bannister GC. Total hip arthroplasty and hemiarthroplasty in mobile, independent patients with a displaced intracapsular fracture of the femoral neck: a randomized, controlled trial. J Bone Joint Surg [Am] 2006;88-A:2583-2589. (Pubitemid 44901944)
21. Blomfeldt R, Törnkvist H, Eriksson K. A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg [Br] 2007;89-B:160-165. (Pubitemid 46421458)
22. Keating JF, Grant A, Masson M, Scott NW, Forbes JF. Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty: treatment of displaced intracapsular hip fractures in healthy older patients. J Bone Joint Surg [Am] 2006;88-A:249-260. (Pubitemid 43185124)
23. Mulroy RD Jr, Harris WH. The effect of improved cementing techniques on component loosening in total hip replacement: an 11-year radiographic review. J Bone Joint Surg [Br] 1990;72-B:757-760. (Pubitemid 20286004)
24. Ellams D, Forsyth O, Mistry A. 7th annual report, 2010. National Joint Registry for England and Wales. http://www.njrcentre.org.uk/njrcentre/ AbouttheNJR/Publicationsandreports/Annualreports/tabid/86/Default.aspx (date last accessed 12 September 2011).
25. Garrelick G, Kärrholm J, Rogmark C, Herberts P. Swedish Hip Arthroplasty Register annual report, 2008. https://www.jru.orthop.gu.se/ (date last accessed 12 September 2011).
26. Graves S, Davidson D, de Steiger R, et al. Annual report, 2007. Australian Association of Orthopaedic Surgeons, National Joint Replacement Registry, 2007. http://www.dmac.adelaide.edu.au/aoanjrr/documents/aoanjrrreport- 2007.pdf (date last accessed 12 September 2011).
27. Davies H, Ollivere B, Motha J, Porteous M, August A. Successful performance of the bi-metric uncemented femoral stem at a minimum follow-up of 13 years in young patients. J Arthroplasty 2010;25:186-190.
28. Harris WH, McCarthy JC Jr, O'Neill DA. Femoral component loosening using contemporary techniques of femoral cement fixation. J Bone Joint Surg [Am] 1982;64-A:1063-1067. (Pubitemid 12031930)
29. Pfahler M, Schidlo C, Refior HJ. Evaluation of imaging in loosening of hip arthroplasty in 326 consecutive cases. Arch Orthop Trauma Surg 1998;117:205-207. (Pubitemid 28176738)
30. Walton NP, Darrah C, Shepstone L, Donell ST, Phillips H. The Elite Plus total hip arthroplasty: the need for radiological surveillance. J Bone Joint Surg [Br] 2005;87-B:458-462.
31. Lübbeke A, Garavaglia G, Barea C, et al. Influence of patient activity on femoral osteolysis at five and ten years following hybrid total hip replacement J Bone Joint Surg [Br] 2011;93-B:456-463.
32. Ye L, Mason MD, Jiang WG. Bone Morphogenic protein and bone metastasis: implication and therapeutic potential. Front Biosci 2011;16:865-897.
33. Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT. The basic science of periprosthetic osteolysis. Instr Course Lect 2001;50:185-195.
34. Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977;11:157-164. (Pubitemid 8059789)
35. Jones LC, Hungerford DS. Cement disease. Clin Orthop 1987;225:192-206. (Pubitemid 18009318)
36. Affatato S, Fernandes B, Tucci A, Esposito L, Toni A. Isolation and morphological characterisation of UHMWPE wear debris generated in vitro. Biomaterials 2001;22:2325-2331. (Pubitemid 32666225)
37. Maloney WJ, Smith RL, Schmalzried TP, et al. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg [Am] 1995;77-A:1301-1310.
38. Shanbhag AS, Jacobs JJ, Glant TT, et al. Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg [Br] 1994;76-B:60-67. (Pubitemid 24029260)
39. Campbell P, Ma S, Yeom B, et al. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995;29:127-131.
40. Horowitz SM, Doty SB, Lane JM, Burstein AH. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg [Am] 1993;75-A:802-813. (Pubitemid 23206694)
41. Catelas I, Petit A, Zukor DJ, et al. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials 1999;20:625-630. (Pubitemid 29126732)
42. Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J Clin Invest 1994;93:1288-1292.
43. Kubo T, Sawada K, Hirakawa K, et al. Histiocyte reaction in rabbit femurs to UHMWPE, metal, and ceramic particles in different sizes. J Biomed Mater Res 1999;45:363-369. (Pubitemid 29196683)
44. Catelas I, Huk OL, Petit A, et al. Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: effects of size, concentration, and composition. J Biomed Mater Res 1988;41:600-607.
45. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty: polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg [Am] 1992;74-A:849-863.
46. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP. The central role of wear debris in periprosthetic osteolysis. HSS J 2006;2:102-113. (Pubitemid 44328104)
47. Blaine TA, Rosier RN, Puzas JE, et al. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg [Am] 1996;78-A:1181-1192. (Pubitemid 26284892)
48. Nakashima Y, Sun DH, Trindade MC, et al. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium- alloy particulate debris in vitro. J Bone Joint Surg [Am] 1999;81-A:603-615. (Pubitemid 29241254)
49. Xu JW, Konttinen YT, Lassus J, et al. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol 1996;14:643-648. (Pubitemid 27013351)
50. Ingham E, Green TR, Stone MH, et al. Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000;21:1005-1013. (Pubitemid 30145691)
51. Clarke SA, Brooks RA, Hobby JL, et al. Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements. Acta Orthop Scand 2001;72:491-498. (Pubitemid 33043589)
52. Wimhurst JA, Brooks RA, Rushton N. Inflammatory responses of human primary macrophages to particulate bone cements in vitro. J Bone Joint Surg [Br] 2001;83-B:278-282. (Pubitemid 32242031)
53. Nakashima Y, Sun DH, Maloney WJ, et al. Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Joint Surg [Br] 1988;80-B:694-700.
54. Kido A, Pap G, Nägler DK, et al. Protease expression in interface tissues around loose arthroplasties. Clin Orthop 2004;425:230-236. (Pubitemid 39062775)
55. Takei I, Takagi M, Santavirta S, et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J Biomed Mater Res 2000;52:613-620.
56. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop 2007;454:251-261. (Pubitemid 46074927)
57. Lohmann CH, Schwartz Z, Köster G, et al. Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials 2000;21:551-561. (Pubitemid 30083919)
58. Vermes C, Chandrasekaran R, Jacobs JJ, et al. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg [Am] 2001;83-A:201-211. (Pubitemid 32163714)
59. Vermes C, Jacobs JJ, Zhang J, et al. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 2002;277:16879-16887. (Pubitemid 34967713)
60. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342. (Pubitemid 40852708)
61. Haynes DR, Crotti TN, Zreiqat H. Regulation of osteoclast activity in peri-implant tissues. Biomaterials 2004;25:4877-4885. (Pubitemid 38520818)
62. Nakashima Y, Sun DH, Trindade MC, et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg [Br] 1999;81-B:155-162. (Pubitemid 29043430)
63. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Viral interleukin- 10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 2002;46:1298-1308. (Pubitemid 34525839)
64. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338-347. (Pubitemid 32105415)
65. Epstein NJ, Warme BA, Spanogle J, et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 2005;23:501-510. (Pubitemid 40631319)
66. Rakshit DS, Ly K, Sengupta TK, et al. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma: mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg [Am] 2006;88-A:788-799.
67. Childs LM, Paschalis EP, Xing L, et al. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002;17:192-199. (Pubitemid 34087651)
68. Wei X, Zhang X, Zuscik MJ, et al. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res 2005;20:1136-1148. (Pubitemid 40863801)
69. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007;(Suppl):1.
70. Boyce BF, Xing L. The RANKL/RANK/OPG pathway. Curr Osteoporos Rep 2007;5:98-104. (Pubitemid 47577320)
71. Haynes DR, Crotti TN, Potter AE, et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg [Br] 2001;83-B:902-911. (Pubitemid 32785565)
72. Mandelin J, Li TF, Liljeström M, et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg [Br] 2003;85-B:1196-1201. (Pubitemid 37461418)
73. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000;15:1459-1466. (Pubitemid 30484515)
74. Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 2002;20:169-173. (Pubitemid 34218258)
75. Ulrich-Vinther M, Carmody EE, Goater JJ, et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg [Am] 2002;84-A:1405-1412. (Pubitemid 35407586)
76. Pioletti DP, Kottelat A. The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 2004;25:5803-5808. (Pubitemid 38681164)
77. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)
78. Schwarz EM, Lu AP, Goater JJ, et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472-480. (Pubitemid 30599625)
79. Boot RG, Verhoek M, de Fost M, et al. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 2004;103:33-39. (Pubitemid 38029915)
80. Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 2004;122:359-369. (Pubitemid 39145540)
81. Boven LA, Van Meurs M, Van Zwam M, et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006;129:517-526. (Pubitemid 43164373)
82. Koulouvaris P, Ly K, Ivashkiv LB, et al. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. J Orthop Res 2008;26:106-116.
83. Bargagli E, Margollicci M, Nikiforakis N, et al. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration 2007;74:548-552. (Pubitemid 47206885)
84. Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005;202:345-351. (Pubitemid 41126951)
85. Humphrey MB, Daws MR, Spusta SC, et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res 2006;21:237-245. (Pubitemid 43265289)
86. Glant TT, Jacobs JJ. Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Orthop Res 1994;12:720-731. (Pubitemid 24323695)
87. Gordon A, Kiss-Toth E, Stockley I, Eastell R, Wilkinson JM. Polymorphisms in the interleukin11 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 2008;58:3157-3165.
88. Wilkinson JM, Wilson AG, Stockley I, et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res 2003;18:1995-2001. (Pubitemid 37377449)
89. Wooley PH, Schwarz EM. Aseptic loosening. Gene Ther 2004;11:402-407. (Pubitemid 38263090)
90. Del Buono A, Denaro V, Maffulli N. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull 2011:Epub.